Biofield CE-marks breast cancer diagnostic system:
This article was originally published in Clinica
Biofield has CE-marked its Biofield diagnostic system for breast cancer detection. It is used in conjunction with a mammography or physical examination in younger women with a dubious palpable breast lesion. The company plans to launch it in Europe later this year
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.